|
| 36260825 | Reirradiation for Recurrent Glioblastoma: What We Know and What We Do Not. | J Clin Oncol | 2023 |
| 37451272 | Tissue factor is a critical regulator of radiation therapy-induced glioblastoma remodeling. | Cancer Cell | 2023 |
| 37342189 | A multicenter, phase 1, dose escalation clinical trial (G-FORCE-1) of XRT, RRx-001 and temozolomide followed by temozolomide +/- RRx-001 in newly diagnosed glioblastoma. | Front Oncol | 2023 |
| 36750401 | Concurrent immunotherapy and re-irradiation utilizing stereotactic body radiotherapy for recurrent high-grade gliomas. | Cancer Rep (Hoboken) | 2023 |
| 36877162 | Microenvironment-Driven Dynamic Chromatin Changes in Glioblastoma Recapitulate Early Neural Development at Single-Cell Resolution. | Cancer Res | 2023 |
| 36732630 | Nuclear condensates in YAP1-driven ependymoma. | Nat Cell Biol | 2023 |
| 34345823 | Outcomes following upfront radiation versus monitoring in atypical meningiomas: 16-year experience at a tertiary medical center. | Neurooncol Adv | 2021 |
| 33542154 | Pluripotent stem cell-derived epithelium misidentified as brain microvascular endothelium requires ETS factors to acquire vascular fate. | Proc Natl Acad Sci U S A | 2021 |
| 33618043 | Foundations of Neuro-Oncology: A Multidisciplinary Approach. | World Neurosurg | 2021 |
| 33558264 | Diffuse Glioma Heterogeneity and Its Therapeutic Implications. | Cancer Discov | 2021 |
| 33610863 | Scientific and Clinical Challenges within Neuro-Oncology. | World Neurosurg | 2021 |
| 34375609 | Optic nerve activity promotes the growth of optic pathway gliomas: Shedding light on the glioma microenvironment. | Cancer Cell | 2021 |
| 34253056 | Next-Generation Human Cerebral Organoids as Powerful Tools To Advance NeuroHIV Research. | mBio | 2021 |
| 34243672 | Innovations in Neuro-Oncology. | World Neurosurg | 2021 |
| 31136748 | Grading meningiomas utilizing multiparametric MRI with inclusion of susceptibility weighted imaging and quantitative susceptibility mapping. | J Neuroradiol | 2020 |
| 33103125 | Generating Patient-Derived Gliomas within Cerebral Organoids. | STAR Protoc | 2020 |
| 33002863 | Incorporating genomic signatures into surgical and medical decision-making for elderly glioblastoma patients. | Neurosurg Focus | 2020 |
| 32721076 | The Prognostic Value of MRI Subventricular Zone Involvement and Tumor Genetics in Lower Grade Gliomas. | J Neuroimaging | 2020 |
| 32253265 | Tumor Microenvironment Is Critical for the Maintenance of Cellular States Found in Primary Glioblastomas. | Cancer Discov | 2020 |
| 30465868 | MRI based texture analysis to classify low grade gliomas into astrocytoma and 1p/19q codeleted oligodendroglioma. | Magn Reson Imaging | 2019 |
| 31792122 | Malignant Gliomas: Simplifying the Complexity. | Cancer Discov | 2019 |
| 31592503 | Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer. | JCO Precis Oncol | 2019 |
| 30779663 | Integrated PET-MRI for Glioma Surveillance: Perfusion-Metabolism Discordance Rate and Association With Molecular Profiling. | AJR Am J Roentgenol | 2019 |
| 30893594 | Modeling Patient-Derived Glioblastoma with Cerebral Organoids. | Cell Rep | 2019 |
| 30882547 | Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma. | J Immunother | 2019 |
| 30644143 | MRI Features Associated with TERT Promoter Mutation Status in Glioblastoma. | J Neuroimaging | 2019 |
| 30617484 | Texture analysis on conventional MRI images accurately predicts early malignant transformation of low-grade gliomas. | Eur Radiol | 2019 |
| 30446900 | Tubular brain tumor biopsy improves diagnostic yield for subcortical lesions. | J Neurooncol | 2019 |
| 30106394 | The REMBRANDT study, a large collection of genomic data from brain cancer patients. | Sci Data | 2018 |
| 28710771 | Detailed longitudinal sampling of glioma stem cells in situ reveals Chr7 gain and Chr10 loss as repeated events in primary tumor formation and recurrence. | Int J Cancer | 2017 |
| 28256619 | A Core Regulatory Circuit in Glioblastoma Stem Cells Links MAPK Activation to a Transcriptional Program of Neural Stem Cell Identity. | Sci Rep | 2017 |
| 26729270 | Concurrent functional and metabolic assessment of brain tumors using hybrid PET/MR imaging. | J Neurooncol | 2016 |
| 26643807 | A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas. | J Neurooncol | 2016 |
| 27471611 | Prioritization schema for immunotherapy clinical trials in glioblastoma. | Oncoimmunology | 2016 |
| 26860632 | A Phase II trial of tandutinib (MLN 518) in combination with bevacizumab for patients with recurrent glioblastoma. | CNS Oncol | 2016 |
| 25250735 | Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date. | Cancer | 2015 |
| 26285768 | A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas. | J Neurooncol | 2015 |
| 26206809 | Glioma Angiogenesis and Perfusion Imaging: Understanding the Relationship between Tumor Blood Volume and Leakiness with Increasing Glioma Grade. | AJNR Am J Neuroradiol | 2015 |
| 26194676 | A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma. | Int J Radiat Oncol Biol Phys | 2015 |
| 25670220 | New strategies in glioblastoma: exploiting the new biology. | Clin Cancer Res | 2015 |
| 25446780 | An in silico screen links gene expression signatures to drug response in glioblastoma stem cells. | Pharmacogenomics J | 2015 |
| 25605863 | Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology. | J Clin Oncol | 2015 |
| 24440720 | ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor-initiating cell state. | Cell Rep | 2014 |
| 25573794 | Correction to "master regulators, regulatory networks, and pathways of glioblastoma subtypes". | Cancer Inform | 2014 |
| 25197555 | Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells. | J Immunother Cancer | 2014 |
| 25314963 | Timing (and biology) are everything. | Neuro Oncol | 2014 |
| 25368508 | Master regulators, regulatory networks, and pathways of glioblastoma subtypes. | Cancer Inform | 2014 |
| 25313237 | Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD). | Neuro Oncol | 2014 |
| 25365423 | Identification of molecular pathways facilitating glioma cell invasion in situ. | PLoS One | 2014 |
| 25098701 | Bevacizumab-related toxicities in the National Cancer Institute malignant glioma trial cohort. | J Neurooncol | 2014 |